ZA94891B - Heteroaromatic compounds - Google Patents

Heteroaromatic compounds

Info

Publication number
ZA94891B
ZA94891B ZA94891A ZA94891A ZA94891B ZA 94891 B ZA94891 B ZA 94891B ZA 94891 A ZA94891 A ZA 94891A ZA 94891 A ZA94891 A ZA 94891A ZA 94891 B ZA94891 B ZA 94891B
Authority
ZA
South Africa
Prior art keywords
heteroaromatic compounds
heteroaromatic
compounds
Prior art date
Application number
ZA94891A
Inventor
Mark Henry Norman
Frank Navas Iii
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA94891B publication Critical patent/ZA94891B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA94891A 1993-02-10 1994-02-09 Heteroaromatic compounds ZA94891B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302622A GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds

Publications (1)

Publication Number Publication Date
ZA94891B true ZA94891B (en) 1995-08-10

Family

ID=10730183

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94891A ZA94891B (en) 1993-02-10 1994-02-09 Heteroaromatic compounds

Country Status (15)

Country Link
EP (1) EP0683778A1 (en)
JP (1) JPH08506337A (en)
CN (1) CN1117731A (en)
AU (1) AU6005194A (en)
BG (1) BG99839A (en)
CA (1) CA2155758A1 (en)
CZ (1) CZ204495A3 (en)
FI (1) FI953777A0 (en)
GB (1) GB9302622D0 (en)
HU (1) HUT73654A (en)
IL (1) IL108601A0 (en)
MX (1) MX9401080A (en)
SK (1) SK99195A3 (en)
WO (1) WO1994018196A1 (en)
ZA (1) ZA94891B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
JP3274579B2 (en) * 1995-01-12 2002-04-15 住友製薬株式会社 Agent for treating psychiatric symptoms associated with cerebrovascular disorders
DE69618050T2 (en) * 1995-03-17 2002-07-11 Aventis Pharmaceuticals Inc., Cincinnati Substituted benzylthienylpiperazines, their use as medicines and processes for their manufacture
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
CA2428519A1 (en) * 2000-11-14 2002-05-23 Merck Patent Gesellschaft Mit Beschraenkter Haftung Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
EP1688412A3 (en) * 2001-02-16 2006-08-16 Aventis Pharmaceuticals, Inc. Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
CN1292749C (en) 2001-07-26 2007-01-03 默克专利股份有限公司 Novel use of 2-[5-(40fluorophenyl)3-pyridylmethylaminomethyl]
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
JP2008506744A (en) * 2004-07-20 2008-03-06 シエナ ビオテク ソシエタ ペル アチオニ Modulators of α7 nicotinic acetylcholine receptors and their use in therapy
CL2008000119A1 (en) 2007-01-16 2008-05-16 Wyeth Corp COMPOUNDS DERIVED FROM PIRAZOL, ANTAGONISTS OF THE NICOTINIC ACETILCOLINE RECEIVER; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS SENILE DEMENTIA, ALZHEIMER AND SCHIZOPHRENIA.
WO2013014665A1 (en) * 2011-07-28 2013-01-31 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625181B2 (en) * 1985-03-27 1994-04-06 住友製薬株式会社 New imide derivative
JP2660407B2 (en) * 1986-09-26 1997-10-08 住友製薬株式会社 New imide derivatives
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives

Also Published As

Publication number Publication date
WO1994018196A1 (en) 1994-08-18
AU6005194A (en) 1994-08-29
GB9302622D0 (en) 1993-03-24
CN1117731A (en) 1996-02-28
MX9401080A (en) 1994-08-31
CA2155758A1 (en) 1994-08-18
BG99839A (en) 1996-02-28
FI953777A (en) 1995-08-09
IL108601A0 (en) 1994-05-30
HUT73654A (en) 1996-09-30
CZ204495A3 (en) 1996-03-13
HU9501881D0 (en) 1995-08-28
FI953777A0 (en) 1995-08-09
JPH08506337A (en) 1996-07-09
SK99195A3 (en) 1995-12-06
EP0683778A1 (en) 1995-11-29

Similar Documents

Publication Publication Date Title
GB9306184D0 (en) Heteroaromatic compounds
GB9304620D0 (en) Compounds
GB9310978D0 (en) Compounds
GB9302016D0 (en) Compounds
GB9302622D0 (en) Heteroaromatic compounds
GB9315801D0 (en) Compounds
GB9313144D0 (en) Compounds
GB9307400D0 (en) Compounds
GB9315800D0 (en) Compounds
GB9317314D0 (en) Compounds
EP0733044A4 (en) Compounds
GB9310459D0 (en) Compounds
GB9309618D0 (en) Compounds
GB9312686D0 (en) Compounds
GB9311766D0 (en) Compounds
GB9312688D0 (en) Compounds
GB9310597D0 (en) Compounds
GB9310595D0 (en) Compounds
GB9310594D0 (en) Compounds
GB9310461D0 (en) Compounds
GB9310460D0 (en) Compounds
GB9313185D0 (en) Compounds
GB9310450D0 (en) Compounds
GB9310425D0 (en) Compounds
GB9310317D0 (en) Compounds